AdaptHealth Investigated for Financial Projections; Investors May Be Affected
Levi & Korsinsky is investigating AdaptHealth Corp. concerning its financial forecasts and cost management, following a significant reduction in earnings guidance.
The law firm Levi & Korsinsky has announced it is investigating AdaptHealth Corp. (NASDAQ: AHCO) over its financial projections and cost management practices. The investigation focuses on the company's disclosures and subsequent revisions to its financial outlook.
AdaptHealth initially provided guidance for its full-year 2026 adjusted EBITDA on May 5, 2026, projecting a range of $680 million to $730 million. At the time, the company stated that elevated labor costs were expected to normalize.
However, weeks later, in early August 2026, AdaptHealth significantly revised its forecast. The company reduced its projected range for full-year 2026 adjusted EBITDA to approximately $490 million to $520 million. This substantial decrease raised concerns among investors regarding the accuracy of the earlier statements.
Levi & Korsinsky is seeking AdaptHealth shareholders who may have incurred losses as a result of these developments. Investors who owned AdaptHealth stock between May and August 2026 and are interested in learning more about the investigation are encouraged to contact the firm.